ReviewFrontiers in pharmacology2022

An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors.

Mithlesh Kumar Temre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.